Part Number
Part Number:
NSN:
NIIN:
Item Name:
PANCRELIPASE TABLETS , USP
Definition:
CAGE Information
| Code | Company |
|---|---|
| 0TX62 | AXCAN PHARMA US INC. |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| FEAT | SPECIAL FEATURES | ENZYME POTENCY PER TABLET IS AMYLASE 30,000 USP UNITS,LIPASE 8000 USP UNITS,AND PROTEASE 30,000 USP UNITS |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| SUPP | SUPPLEMENTARY FEATURES | PORCINE OR BOVINE ORIGIN |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 325.000 MILLIGRAMS PANCREATIN ACTIVE INGREDIENT |
| CSGS | ADMINISTRATION | ORAL |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | PANCRELIPASE TABLETS USP 325 MG 500S BT |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |